for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Oncolytics Biotech Receives Final Advice Letter From European Medicines Agency For Reolysin In Metastatic Breast Cancer

Dec 5 (Reuters) - Oncolytics Biotech Inc:

* ONCOLYTICS BIOTECH® RECEIVES FAVORABLE FINAL ADVICE LETTER FROM THE EUROPEAN MEDICINES AGENCY FOR REOLYSIN® IN METASTATIC BREAST CANCER

* ONCOLYTICS BIOTECH INC - PROPOSED PHASE 3 STUDY DESIGN IS FOUND ACCEPTABLE AND CAN FORM BASIS OF A MARKETING AUTHORIZATION APPLICATION

* ONCOLYTICS BIOTECH INC - EMA ADVICE CONSISTENT WITH FEEDBACK RECEIVED FROM FDA PAVING WAY FOR A GLOBAL PHASE 3 STUDY Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up